This inventor holds 1 USPTO granted patent. Top assignees: Beth Israel Deaconess Medical Center, Inc., Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 539 
1 out of 8,600 
1 out of 3,079 
Years Active: 2025
Title: Mo Motamedi: Innovator in Cancer Research
Introduction
Mo Motamedi is a prominent inventor based in Boston, MA, known for his significant contributions to cancer research. He has developed innovative solutions aimed at addressing the challenges of cancer chemoresistance. His work is crucial in the ongoing fight against cancer, providing new avenues for treatment.
Latest Patents
Mo Motamedi holds a patent for "Compounds, pharmaceutical compositions, and methods of their use in reversing cancer chemoresistance." This patent describes various compounds and pharmaceutical compositions that can be utilized to combat the resistance that cancer cells often develop against chemotherapy.
Career Highlights
Throughout his career, Mo has worked with esteemed organizations such as The General Hospital Corporation and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Junichi Hanai and Vikas P Sukhatme. Their collaborative efforts have further advanced the understanding and treatment of cancer.
Conclusion
Mo Motamedi's innovative work in cancer research exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for more effective cancer treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile